Advocacy Updates


Pew reports highlight importance of antibiotic stewardship

The Pew Charitable Trusts issued two reports on antibiotic stewardship. “A Path to Better Antibiotic Stewardship in Inpatient Settings” illustrates the multiple approaches to successful antibiotic stewardship programs (ASP) by providing case studies of ASPs in 10 inpatient facilities. The report’s key findings identified common factors critical to the success of the programs, including having … Continue reading “Pew reports highlight importance of antibiotic stewardship”


FDA lacks sterility assurance for Medaus products

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals and patients not to use unexpired drug products that are intended to be sterile that were produced by Medaus Pharmacy in Birmingham, Alabama, due to lack of sterility assurance. Medaus’ products were distributed nationwide and internationally. FDA advises checking medical supplies immediately, and any … Continue reading “FDA lacks sterility assurance for Medaus products”


ASTHO toolkit to facilitate information exchange during HAI outbreaks

The Association of State and Territorial Health Officials (ASTHO) released a web-based toolkit, Improving Your Access to Electronic Health Records (EHRs) During Outbreaks of Healthcare-associated Infections. The toolkit is designed to help health agencies improve information exchange with healthcare facilities for outbreak investigation. Developed in partnership with CDC and the Keystone Policy Center, the toolkit … Continue reading “ASTHO toolkit to facilitate information exchange during HAI outbreaks”


Zika policy updates

•The U.S. Food and Drug Administration (FDA) announced the availability of an investigational test to screen blood donations for Zika virus. The screening test may be used under an investigational new drug application (IND) for screening donated blood in areas with active mosquito-borne transmission of Zika virus. Read the FDA announcement. •The CDC hosted the Zika … Continue reading “Zika policy updates”


Notice of counterfeit N95 respirators

The National Institute for Occupational Safety and Health (NIOSH) has become aware of a counterfeit N95 Respirator on the market. While the TC number and private label holder (KOSTO) are valid, this unapproved unit can be identified by the misspelling of NIOSH on the front of the respirator. Read the NIOSH respirator user notice.